Travere Therapeutics, Inc. logo TVTX - Travere Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 15
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $51.50 DETAILS
HIGH: $54.00
LOW: $49.00
MEDIAN: $51.50
CONSENSUS: $51.50
UPSIDE: 15.91%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2008
Revenue
Revenue 490.7 233.2 145.2 109.5 131.8 198.3 175.3 164.2 154.9 133.6 99.9 28.2 0 0 0 0
Cost of Revenue 10.3 7.7 11.4 4.4 3.8 6.1 5.2 5.5 3.6 4.6 2.2 0.6 0 0 0 0
Gross Profit 480.4 225.4 133.8 105.0 128.0 192.2 170.1 158.7 151.3 129.0 97.7 27.6 0 0 0 0
Operating Expenses
R&D Expenses 206.0 282.7 245.0 227.3 201.2 131.8 141.0 123.8 78.2 70.9 50.4 47.8 7.1 0.7 0 0
SG&A Expenses 337.2 264.1 265.5 197.5 126.3 135.8 129.0 103.7 104.0 98.0 79.5 59.6 16.9 30.3 0.0 0.0
Other Expenses 0 2.4 11.4 0 0 100.8 (0.3) (0.5) 1.1 (0.3) (0.3) 0 0 28,964.7 0 0
Operating Expenses 543.2 549.3 521.9 424.9 327.4 368.4 269.9 227.4 182.1 168.9 130.0 107.4 24.0 30.3 0.0 0.0
Operating Income
Operating Income (62.8) (323.8) (388.1) (319.8) (199.4) (176.2) (99.8) (80.0) (53.8) (58.2) (50.7) (79.8) (24.0) (30.2) (0.0) (0.0)
Interest Expense 10.7 11.2 11.3 11.0 19.7 19.1 18.8 9.8 4.4 4.7 0 0 19.5 0.1 0.0 0
Interest Income 12.7 17.8 21.8 6.3 2.0 5.0 10.1 5.5 3.2 4.0 7.7 7.4 0 0.0 0 0
Profitability
EBITDA 22.2 (265.8) (326.2) (299.4) (184.5) (145.2) (107.2) (73.4) (38.7) (38.8) 129.5 (74.1) (34.3) (30.1) (0.0) (0.0)
EBIT (38.5) (309.3) (364.8) (320.1) (197.2) (169.7) (127.6) (92.1) (53.9) (52.8) 113.2 (79.8) (34.5) (30.2) 0 (0.0)
Income Before Tax (49.3) (320.5) (376.1) (331.2) (216.9) (188.8) (146.4) (101.9) (58.4) (57.6) 105.5 (113.4) (33.7) (30.3) (0.0) (0.0)
Income Tax Expense 1.0 0.1 0.2 0.3 0.4 (19.4) (0.0) 0.8 1.4 (9.7) (11.8) (2.5) 0.1 0.0 0 0
Net Income (25.5) (321.5) (111.4) (278.5) (180.1) (169.4) (146.4) (102.7) (59.7) (47.9) 117.2 (110.9) (33.8) (30.3) (0.0) (0.0)
Per Share Data
EPS (Basic) -0.56 -4.08 -1.50 -4.37 -3.01 -3.56 -3.46 -2.54 -1.54 -1.29 3.49 -4.43 -2.38 -284.40 -0.14 -0.00
EPS (Diluted) -0.56 -4.08 -1.50 -4.37 -3.01 -3.56 -3.46 -2.54 -1.54 -1.25 3.17 -4.43 -2.38 -284.40 -0.14 -0.00
Shares Outstanding 89.2 78.9 74.3 63.8 59.8 47.5 42.3 40.4 38.8 37.0 33.6 25.0 14.2 0.1 0.1 95.9
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2008
Current Assets
Cash & Cash Equivalents 93.0 58.5 58.2 61.7 165.8 84.8 62.4 102.9 99.4 41.0 0.0
Short-Term Investments 229.8 312.2 508.7 388.6 387.1 276.8 336.1 368.7 201.2 214.9 0
Net Receivables 80.1 27.1 21.2 16.6 15.9 33.1 18.0 14.5 13.9 65.4 0
Inventory 5.9 6.2 9.4 4.5 7.3 7.6 6.1 5.6 5.4 2.8 0
Other Current Assets 28.8 12.7 19.3 15.0 0.2 0 5.0 2.3 6.0 4.8 0
Total Current Assets 437.6 416.7 616.8 486.4 582.8 410.4 429.1 495.7 325.8 332.4 0.0
Non-Current Assets
Property, Plant & Equipment 14.6 19.6 25.5 30.0 34.3 9.4 9.9 3.1 3.2 2.6 0
Goodwill 0 0.8 0.8 0.8 0.9 0.9 0.9 0.9 0.9 0.9 0
Intangible Assets 113.9 103.2 103.7 96.3 147.5 153.2 157.2 186.7 184.8 182.0 0
Long-Term Investments 0 0 0 0 0 0 0 15 (16.8) (6.4) 0
Other Non-Current Assets 39.2 53.8 42.2 59.0 11.1 33.5 7.7 (25.0) 5.6 7.4 0
Total Non-Current Assets 167.6 177.4 172.1 186.2 193.8 197.0 175.7 213.5 194.5 192.9 0
Total Assets 605.2 594.1 788.9 672.6 776.6 607.4 604.8 709.2 520.3 525.3 0.0
Current Liabilities
Account Payables 24.8 23.5 41.7 17.3 15.1 12.1 26.6 7.0 18.9 7.5 0.0
Short-Term Debt 5.9 68.7 0 0 0 0 2.6 22.5 0 0 0.0
Deferred Revenue 0 2.8 7.1 12.0 16.3 0 0 49.7 0 0 0
Other Current Liabilities 129.2 100.3 94.3 48.0 39.6 62.3 52.2 64.8 59.0 68.3 0.0
Total Current Liabilities 159.9 200.8 177.9 142.2 124.1 92.7 95.4 104.6 85.7 83.3 0.0
Non-Current Liabilities
Long-Term Debt 322.9 310.3 377.3 375.5 226.6 215.3 204.9 195.1 45.1 44.4 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 32.7 16.8 6.4 0
Other Non-Current Liabilities 7.6 6.8 8.5 73.6 72.0 59.9 75.9 91.2 96.5 83.4 0
Total Non-Current Liabilities 330.5 334.3 410.2 487.6 350.4 303.6 288.2 286.3 141.5 134.3 0
Total Liabilities 490.4 535.0 588.1 629.7 474.5 396.2 383.6 390.9 227.2 217.5 0.0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0
Retained Earnings (1,472.7) (1,447.2) (1,125.6) (1,014.2) (766.0) (585.9) (416.4) (270.0) (177.7) (113.1) (0.1)
Accumulated Other Comprehensive Income (1.2) (0.1) (1.5) (2.9) (0.6) (0.9) 0.7 (1.5) (1.0) (0.5) 0
Total Stockholders' Equity 114.8 59.1 200.8 42.9 302.1 211.2 221.2 318.3 293.1 307.8 0
Total Liabilities & Equity 605.2 594.1 788.9 672.6 776.6 607.4 604.8 709.2 520.3 525.3 0.0
Debt Metrics
Total Debt 328.7 401.6 404.8 407.5 262.0 244.0 214.9 217.5 45.1 44.4 0.0
Net Debt 235.7 343.0 346.6 345.8 96.2 159.3 152.4 114.7 (54.3) 3.4 (0.0)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income (25.5) (320.6) (376.3) (331.5) (217.3) (169.4) (146.4) (102.7) (59.7) (47.9)
Depreciation & Amortization 60.7 43.6 38.5 20.7 12.7 24.6 20.4 18.7 17.8 16.1
Stock-Based Compensation 44.9 36.9 44.2 38.1 29.6 23.6 21.1 19.8 26.9 29.1
Change in Working Capital (14.0) (63.0) (25.5) 0.9 80.8 (26.0) 2.6 11.1 3.8 5.5
Other Non-Cash Items (28.3) 65.7 39.0 85.4 79.4 102.5 44.1 7.9 25.1 18.3
Operating Cash Flow 37.8 (237.5) (280.0) (186.3) (14.8) (42.7) (58.2) (25.0) 7.4 (1.6)
Investing Activities
Capital Expenditure 0 (101.2) (41.6) (28.4) (24.2) (119.8) (15.6) (19.7) (14.0) (11.9)
Acquisitions 0 0 0 0 0 113.1 0 (15) (13.1) (0.5)
Purchases of Investments (237.1) (125.8) (443.9) (385.4) (547.1) (215.0) (223.7) (331.3) (102.4) (184.1)
Sales/Maturities of Investments 323.6 326.3 334.6 382.0 433.6 273.5 259.1 162.8 114.5 159.5
Other Investing Activities (58.6) (101.3) 165.8 (29.0) (19.1) (113.1) (15.4) (202.6) 60.6 47.4
Investing Cash Flow 27.9 99.3 55.8 (32.6) (137.6) (61.3) 19.9 (203.3) 45.6 10.4
Financing Activities
Net Debt Issuance (68.9) 0 0 104.9 0 0 0 235.8 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (2.1) 4.7 27.6 (6.9) 6.7 (3.8) (2.1) (3.9) 5.4 (5.7)
Financing Cash Flow (33.5) 139.4 218.8 117.6 231.7 127.7 (2.1) 231.9 5.4 (5.7)
Cash Position
Net Change in Cash 34.5 0.4 (3.5) (104.1) 81.0 22.3 (40.4) 3.5 58.4 3.2
Cash at Beginning 58.5 58.2 61.7 165.8 84.8 62.4 102.9 99.4 41.0 37.8
Cash at End 93.0 58.5 58.2 61.7 165.8 84.8 62.4 102.9 99.4 41.0
Free Cash Flow 37.8 (338.7) (321.6) (214.7) (38.9) (162.6) (73.8) (44.7) (6.6) (13.5)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2008
Income Statement
Revenue 490.7 233.2 145.2 109.5 131.8 198.3 175.3 164.2 154.9 133.6 99.9 28.2 0 0 0 0
Gross Profit 480.4 225.4 133.8 105.0 128.0 192.2 170.1 158.7 151.3 129.0 97.7 27.6 0 0 0 0
Operating Income (62.8) (323.8) (388.1) (319.8) (199.4) (176.2) (99.8) (80.0) (53.8) (58.2) (50.7) (79.8) (24.0) (30.2) (0.0) (0.0)
Net Income (25.5) (321.5) (111.4) (278.5) (180.1) (169.4) (146.4) (102.7) (59.7) (47.9) 117.2 (110.9) (33.8) (30.3) (0.0) (0.0)
EPS (Diluted) -0.56 -4.08 -1.50 -4.37 -3.01 -3.56 -3.46 -2.54 -1.54 -1.25 3.17 -4.43 -2.38 -284.40 -0.14 -0.00
Balance Sheet
Cash & Equivalents 93.0 58.5 58.2 61.7 165.8 84.8 62.4 102.9 99.4 41.0 0.0
Total Assets 605.2 594.1 788.9 672.6 776.6 607.4 604.8 709.2 520.3 525.3 0.0
Total Debt 328.7 401.6 404.8 407.5 262.0 244.0 214.9 217.5 45.1 44.4 0.0
Stockholders' Equity 114.8 59.1 200.8 42.9 302.1 211.2 221.2 318.3 293.1 307.8 0
Cash Flow
Operating Cash Flow 37.8 (237.5) (280.0) (186.3) (14.8) (42.7) (58.2) (25.0) 7.4 (1.6)
Capital Expenditure 0 (101.2) (41.6) (28.4) (24.2) (119.8) (15.6) (19.7) (14.0) (11.9)
Free Cash Flow 37.8 (338.7) (321.6) (214.7) (38.9) (162.6) (73.8) (44.7) (6.6) (13.5)